Tokyo, Oct 30, 2009 - (JCN Newswire) - Eisai Co., Ltd. today announced that the company has concluded a strategic collaboration agreement with Quintiles, a world leading biopharmaceutical services company, to develop six anticancer compounds in its oncology pipeline to
» Full text »
